StockData
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. (ORMP) stock

ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.87−0.03 (-0.77%)

Close on Nov 17, 2026Market cap $160.98MP/E 0.9Yield 6.46%

Oramed Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Oramed Pharmaceuticals's market cap was $170.63M on Nov 11, 2026, against $116.39M a year earlier. Over the last 5 years it ranged from $70.23M to $504.00M, with a median of $120.65M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$170.63M+46.6%
2025Dec 31, 2025$116.39M+19.6%
2024Dec 31, 2024$97.31M+4.6%
2023Dec 29, 2023$93.05M-78.1%
2022Dec 30, 2022$424.59M-15.8%
2021Dec 31, 2021$504.00M+402.1%
2020Dec 31, 2020$100.38M+12.1%
2019Dec 31, 2019$89.52M+71.8%
2018Dec 31, 2018$52.11M-57.6%
2017Dec 29, 2017$123.02M+52.5%
2016Dec 30, 2016$80.68M-18.4%
2015Dec 31, 2015$98.86M+114.6%
2014Dec 31, 2014$46.07M-62.4%
2013Dec 31, 2013$122.48M+363.4%
2012Dec 31, 2012$26.43M+34.6%
2011Dec 30, 2011$19.63M–

More Oramed Pharmaceuticals figures

See a number that looks wrong?